Antibody trapping is a recently described strategy for immune evasion observed in the intestinal trematode Echinostoma caproni, which may aid to avoiding the host humoral response, thus facilitating parasite survival in the presence of high levels of local-specific antibodies. Parasite-derived peptidases carry out the degradation of trapped antibodies, being essential for this mechanism. Herein, we show that cathepsin-like cysteine endopeptidases are active in the excretory/secretory products (ESPs) of E. caproni and play an important role in the context of antibody trapping. Cysteine endopeptidase activity was detected in the ESPs of E. caproni adults. The affinity probe DCG-04 distinguished a cysteine peptidase band in ESPs, which was specifically recognized by an anti-cathepsin L heterologous antibody. The same antibody localized this protein in the gut and syncytial tegument of adult worms. Studies with cultured parasites showed that in vivo-bound antibodies are removed from the parasite surface in the absence of peptidase inhibitors, while addition of cathepsin L inhibitor prevented their degradation. These results indicate that cathepsin L-like peptidases are involved in the degradation of surface-trapped antibodies and suggest that cysteine peptidases are not only crucial for tissue-invading trematodes, but they can be equally relevant at the parasite-host interface in gut-dwelling flukes.

Área de Parasitología Departamento de Farmacia y Tecnología Farmacéutica y Parasitología Facultad de Farmacia Universitat de València Avda Vicent Andrés Estellés s n 46100 Burjassot Valencia Spain

Department of Parasitology Faculty of Science Charles University Viničná 7 128 44 Prague 2 Czech Republic

Zobrazit více v PubMed

J Parasitol. 2006 Aug;92(4):803-16 PubMed

Adv Exp Med Biol. 2011;712:116-35 PubMed

Exp Parasitol. 2000 Feb;94(2):99-110 PubMed

Int J Parasitol. 2005 Jul;35(8):895-910 PubMed

Infect Immun. 2003 Feb;71(2):838-44 PubMed

Exp Parasitol. 2007 Aug;116(4):390-8 PubMed

J Proteomics. 2013 Aug 26;89:202-14 PubMed

J Pharm Pharmacol. 2008 Jan;60(1):63-70 PubMed

Adv Parasitol. 2009;69:147-204 PubMed

Int J Parasitol. 2008 Apr;38(5):493-502 PubMed

Parasitology. 1997 Feb;114 ( Pt 2):105-12 PubMed

Mol Cell Proteomics. 2008 Jun;7(6):1111-23 PubMed

Infect Immun. 1999 Apr;67(4):1954-61 PubMed

Trends Ecol Evol. 2008 Jun;23(6):318-26 PubMed

Parasit Vectors. 2018 Mar 6;11(1):142 PubMed

PLoS Negl Trop Dis. 2017 Jul 17;11(7):e0005773 PubMed

Adv Parasitol. 2010;72:305-50 PubMed

Lancet. 2014 Jun 28;383(9936):2253-64 PubMed

Mol Biochem Parasitol. 2010 Mar;170(1):7-16 PubMed

Trends Biochem Sci. 2008 Dec;33(12):601-8 PubMed

J Parasitol. 2005 Aug;91(4):978-80 PubMed

Int J Parasitol. 2012 May 1;42(5):481-8 PubMed

PLoS One. 2012;7(9):e45974 PubMed

Trends Parasitol. 2011 Jul;27(7):288-93 PubMed

J Helminthol. 1993 Sep;67(3):179-88 PubMed

Cell Microbiol. 2006 Jun;8(6):1034-46 PubMed

Mol Biochem Parasitol. 2002 Mar;120(1):1-21 PubMed

Microbes Infect. 2012 Apr;14(4):301-10 PubMed

Parasitology. 2003 Jul;127(Pt 1):69-77 PubMed

Int J Parasitol. 1989 Feb;19(1):111-8 PubMed

Mol Biochem Parasitol. 1993 Nov;62(1):9-17 PubMed

Parasit Vectors. 2016 Mar 31;9:185 PubMed

Adv Parasitol. 2009;69:205-97 PubMed

J Biol Chem. 2004 Apr 23;279(17):17038-46 PubMed

Parasite Immunol. 2015 Jan;37(1):32-42 PubMed

Trends Parasitol. 2005 Jun;21(6):251-4 PubMed

Mol Cell Proteomics. 2002 Jan;1(1):60-8 PubMed

Mol Cell Proteomics. 2012 Nov;11(11):1340-53 PubMed

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9298-303 PubMed

Gastroenterology. 1994 Jul;107(1):180-8 PubMed

Parasitology. 2007 Oct;134(Pt 11):1599-609 PubMed

Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G211-9 PubMed

PLoS Negl Trop Dis. 2011 Jun;5(6):e1208 PubMed